1. Home
  2. ELDN vs MXF Comparison

ELDN vs MXF Comparison

Compare ELDN & MXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • MXF
  • Stock Information
  • Founded
  • ELDN 2004
  • MXF 1981
  • Country
  • ELDN United States
  • MXF Mexico
  • Employees
  • ELDN N/A
  • MXF N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • MXF Trusts Except Educational Religious and Charitable
  • Sector
  • ELDN Health Care
  • MXF Finance
  • Exchange
  • ELDN Nasdaq
  • MXF Nasdaq
  • Market Cap
  • ELDN 202.4M
  • MXF 239.1M
  • IPO Year
  • ELDN N/A
  • MXF N/A
  • Fundamental
  • Price
  • ELDN $2.59
  • MXF $18.42
  • Analyst Decision
  • ELDN Strong Buy
  • MXF
  • Analyst Count
  • ELDN 2
  • MXF 0
  • Target Price
  • ELDN $12.50
  • MXF N/A
  • AVG Volume (30 Days)
  • ELDN 683.9K
  • MXF 27.4K
  • Earning Date
  • ELDN 08-14-2025
  • MXF 01-01-0001
  • Dividend Yield
  • ELDN N/A
  • MXF 4.70%
  • EPS Growth
  • ELDN N/A
  • MXF N/A
  • EPS
  • ELDN 0.21
  • MXF N/A
  • Revenue
  • ELDN N/A
  • MXF N/A
  • Revenue This Year
  • ELDN N/A
  • MXF N/A
  • Revenue Next Year
  • ELDN N/A
  • MXF N/A
  • P/E Ratio
  • ELDN $12.78
  • MXF N/A
  • Revenue Growth
  • ELDN N/A
  • MXF N/A
  • 52 Week Low
  • ELDN $2.38
  • MXF $14.77
  • 52 Week High
  • ELDN $5.54
  • MXF $19.49
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 41.11
  • MXF 60.54
  • Support Level
  • ELDN $2.54
  • MXF $18.05
  • Resistance Level
  • ELDN $2.84
  • MXF $18.50
  • Average True Range (ATR)
  • ELDN 0.13
  • MXF 0.22
  • MACD
  • ELDN 0.03
  • MXF -0.01
  • Stochastic Oscillator
  • ELDN 22.73
  • MXF 88.41

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About MXF Mexico Fund Inc. (The)

Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: